- Home
- FXNC vs ADCT Comparison
FXNC vs ADCT Comparison
Compare FXNC & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FXNC
- ADCT
- Stock Information
- Founded
- FXNC 1907
- ADCT 2011
- Country
- FXNC United States
- ADCT Switzerland
- Employees
- FXNC N/A
- ADCT N/A
- Industry
- FXNC Major Banks
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- FXNC Finance
- ADCT Health Care
- Exchange
- FXNC Nasdaq
- ADCT Nasdaq
- Market Cap
- FXNC 203.6M
- ADCT 224.3M
- IPO Year
- FXNC N/A
- ADCT 2020
- Fundamental
- Price
- FXNC $25.16
- ADCT $1.64
- Analyst Decision
- FXNC Strong Buy
- ADCT Strong Buy
- Analyst Count
- FXNC 1
- ADCT 5
- Target Price
- FXNC $21.00
- ADCT $8.00
- AVG Volume (30 Days)
- FXNC 15.1K
- ADCT 543.8K
- Earning Date
- FXNC 02-11-2025
- ADCT 03-12-2025
- Dividend Yield
- FXNC 2.46%
- ADCT N/A
- EPS Growth
- FXNC N/A
- ADCT N/A
- EPS
- FXNC 1.12
- ADCT N/A
- Revenue
- FXNC $48,803,000.00
- ADCT $70,717,000.00
- Revenue This Year
- FXNC N/A
- ADCT $6.81
- Revenue Next Year
- FXNC $41.13
- ADCT $11.23
- P/E Ratio
- FXNC $22.37
- ADCT N/A
- Revenue Growth
- FXNC N/A
- ADCT N/A
- 52 Week Low
- FXNC $14.50
- ADCT $1.55
- 52 Week High
- FXNC $26.00
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- FXNC 72.96
- ADCT 39.86
- Support Level
- FXNC $24.89
- ADCT $1.56
- Resistance Level
- FXNC $25.44
- ADCT $1.75
- Average True Range (ATR)
- FXNC 0.46
- ADCT 0.11
- MACD
- FXNC 0.21
- ADCT 0.00
- Stochastic Oscillator
- FXNC 100.00
- ADCT 17.39
About FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. Loan products and services include personal loans, residential mortgages, home equity loans, and commercial loans. Deposit products and services include checking and savings. The Bank's wealth management division offers estate planning, investment management of assets, retirement accounts, and estate settlement.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.